Dong Lianhua, Meng Ying, Sui Zhiwei, Wang Jing, Wu Liqing, Fu Boqiang
National Institute of Metrology, Beijing, 100029, P. R. China.
Hubei Institute of Measurement and Testing Technology, 430223, Wuhan, P. R. China.
Sci Rep. 2015 Aug 25;5:13174. doi: 10.1038/srep13174.
Digital polymerase chain reaction (dPCR) is a unique approach to measurement of the absolute copy number of target DNA without using external standards. However, the comparability of different dPCR platforms with respect to measurement of DNA copy number must be addressed before dPCR can be classified fundamentally as an absolute quantification technique. The comparability of four dPCR platforms with respect to accuracy and measurement uncertainty was investigated by using a certified plasmid reference material. Plasmid conformation was found to have a significant effect on droplet-based dPCR (QX100 and RainDrop) not shared with chip-based QuantStudio 12k or BioMark. The relative uncertainty of partition volume was determined to be 0.7%, 0.8%, 2.3% and 2.9% for BioMark, QX100, QuantStudio 12k and RainDrop, respectively. The measurements of the certified pNIM-001 plasmid made using the four dPCR platforms were corrected for partition volume and closely consistent with the certified value within the expended uncertainty. This demonstrated that the four dPCR platforms are of comparable effectiveness in quantifying DNA copy number. These findings provide an independent assessment of this method of determining DNA copy number when using different dPCR platforms and underline important factors that should be taken into consideration in the design of dPCR experiments.
数字聚合酶链反应(dPCR)是一种无需使用外部标准即可测量目标DNA绝对拷贝数的独特方法。然而,在将dPCR从根本上归类为绝对定量技术之前,必须先解决不同dPCR平台在DNA拷贝数测量方面的可比性问题。通过使用经认证的质粒参考物质,研究了四种dPCR平台在准确性和测量不确定度方面的可比性。发现质粒构象对基于液滴的dPCR(QX100和RainDrop)有显著影响,而基于芯片的QuantStudio 12k或BioMark则没有这种影响。BioMark、QX100、QuantStudio 12k和RainDrop的分配体积相对不确定度分别确定为0.7%、0.8%、2.3%和2.9%。使用四种dPCR平台对经认证的pNIM-001质粒进行的测量针对分配体积进行了校正,并且在扩展不确定度范围内与认证值密切一致。这表明这四种dPCR平台在定量DNA拷贝数方面具有可比的有效性。这些发现为使用不同dPCR平台时确定DNA拷贝数的这种方法提供了独立评估,并强调了在dPCR实验设计中应考虑的重要因素。